Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Miska, Jason
Assistant Professor
Bio
The goal of Dr. Miska's research is to determine how the metabolism of immune cells within glioblastoma contributes to immune suppression and tumor recurrence. Furthermore, the long-term goal of ... [more]
Mittal, Bharat B.
Professor
Bio
Research interests include use of innovative treatment modalities for head and neck cancer in order to obtain better tumor control and decrease toxicity of treatment.
Mohindra, Nisha
Associate Professor
Bio
Her research interests focus on the clinical investigation of novel agents or combination therapies for non-small cell and small cell lung cancer. She is also interested in developing quality of life ... [more]
Moreira, Jonathan
Associate Professor
Bio
Dr. Moreira's research interests include protocol development for novel therapeutic agents for stem cell transplant conditioning regimens, management of graft vs. host disease, and novel therapeu... [more]
Mulcahy, Mary F.
Professor
Bio
Colon cancer, Esophagus cancer, Gastric cancer, Hepatocellular cancer, Pancreas cancer, Rectal cancer
Patel, Hiten
Assistant Professor
Bio
Dr. Patel is a urologist specializing in urologic oncology. He is a clinical investigator focusing on improving the diagnosis and management of prostate cancer and kidney cancer. His prior work has fo... [more]
Patel, Jyoti D.
Professor
Bio
I am a medical oncologist with expertise in clinical and translational research in thoracic cancers and clinical drug development. I have led multiple clinical trials with novel drugs at all levels, f... [more]
Perlman, Elizabeth
Professor
Bio
Dr. Elizabeth Perlman is a clinician scientist whose predominant clinical role is to serve as the central pathology reviewer for the Children's Oncology Group Renal Tumor Committee. In this capac... [more]
Peter, Marcus
Professor
Bio
Dr. Peter has been working in the apoptosis and death receptor field for 19 years. His initial work in 1995 described the first multiprotein complex in apoptosis, the CD95 death-inducing signaling com... [more]
Plant, Ashley
Associate Professor
Bio
My research is focused on understanding the immune microenvironment of pediatric brain tumors and the role of immunotherapy in the treatment of pediatric brain tumors.